← Stocks · GOVX record
Signal record & history · Trifecta Signals
GeoVax has been flagged by the Trifecta screener 2 times since 2022. 1 signal confirmed; the median confirmed signal is down 100.0% since its Early Signal.
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
Headline statistics: confirmed signals only, measured from the confirmation price.
First signal Jul 2022 · Latest Sep 2022 · Confirmed 1 of 2 Early · Latest close in the chart data: Thu, Nov 5, 2026
Groups are mutually exclusive — every confirmed signal sits in exactly one.
Since July 2022, GeoVax has had two Early signals, one confirmed. Its one decided signal gained +10% within 90 days, and it did not finish ahead of the S&P 500 since confirmation. One Early signal never confirmed and counts in no statistic.
Every Early signal in the record, newest first.
Members see every signal below, and the group mix above.
Membership unlocks the complete signal timeline for GOVX and every other stock in the record — group tags, caution flags, and the full screener.
Already a member? Sign in and this page unlocks.
GeoVax Labs is classified in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. At a market value of about $1.5 million, it sits in the small-cap group.
GeoVax Labs’ standout Trifecta run followed a September 2022 confirmation, falling about 57% over the next 90 days. On classification, its latest signal was rated Low Quality, revenue was shrinking by about 68% at the time, and it sat in the large-cap group when that signal fired.
The stock closed Thursday, November 5 at $0.16, down 6.0% on the day. Over the past week, the shares have traded in a narrow range between about $0.16 and $0.17.
